Brain magnetic resonance imaging findings in patients with systemic sclerosis

International Journal of Rheumatic Diseases

Volumn 13, Issue 1, 2010, Pages 61-67

  Mohamed, Reem H A ^a   Nassef, Amr A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Central nervous system; Magnetic resonance imaging; Peripheral vascular disease; Systemic sclerosis; White matter hyperintense foci

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEADACHE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SYNCOPE; SYSTEMIC SCLEROSIS;

ADULT; BRAIN; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SCLERODERMA, SYSTEMIC;

EID: 75649103222     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01453.x     Document Type: Article

References (16)

1. Pearson JD. The endothelium: its role in scleroderma. Ann Rheum Dis 1991, 50:866-71.
2. Blann AD, Illingworth K, Layson MIV. Mechanisms of endothelial damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993, 20:1325-30.
3. Cutolo M, Sulli A, Pizzorni C. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000, 27:155-60.
4. Blaszczyk M, Krolicki L, Krasu M. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coupe de sabre. J Rheumatol 2003, 30:1997-2004.
5. Chung MH, Sum J, Morrel MJ. DS.Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings. Ann Neurol 1995, 37:679-81.
6. Stone J, Franks AJ, Gutherie JA. Scleroderma " en coup de sabre": pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 2001, 70:382-5.
7. Sardanelli F, Lozzelli A, Cotticelli B. White matter hyperintensities on brain magnetic resonance in systemic sclerosis. Ann Rheum Dis 2005, 64:777-9.
8. Pathak R, Gabor AJ. Scleroderma and central nervous system vasculitis. Stroke 1991; Mar, 22(3):410-13.
9. Fornes P, Chatellier J, Emmerich J. Central nervous system involvement in scleroderma. Ann Med Interne 2002, 153(3):179-82.
10. Andonopoulos AP, Maraziotis T, Yarmenitis S. Multiple spontaneous intracerebral haemorrhage in a patient with progressive systemic sclerosis. Rev Rhuem Engl Ed 1998, 65:437-40.
11. Cutolo M, Nobili F, Sulli A. Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology 2000, 39:1366-73.
12. Burgener FA, Burgener FA, Tan RK, Meyers SP, Zaunbauer W. MRI brain. Differential Diagnosis in MRI 2002, 4. In, eds, p, Theime, Germany
13. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic committee. Arthritis Rheum 1993, 23:22-33.
14. Seibold JR, Kelley WN, Harris ED, Ruddy S, Sledge CB. Scleroderma. Text Book of Rheumatology 1997, 1133-62. In, eds, 5th edn, pp, Saunders, Philadelphia
15. Osborne AG, Osborne AG. Acquired metabolic, white matter, and degenerative diseases of the brain. Diagnostic Neuroradiology 1994, 2. In, ed, 2nd edn, p, Mosby, USA
16. Burgener FA, Burgener FA, Tan RK, Meyers SP, Zaunbauer W. Multiple or diffuse lesions involving the white matter. Differential Diagnosis in MRI 2002, 100. In, eds, p, Theime, Germany